On August 13, 2025, NeOnc Technologies Holdings, Inc. (the "Company") discovered that in its Form 10-Q for the quarter ended March 31, 2025 as filed with the Securities and Exchange Commission on May 9, 2025 (the "March 31, 2025 Form 10-Q"), it had inadvertently overstated non-cash share-based compensation expense related to 1,486,667 restricted stock units ("RSUs") issued on January 4, 2024, to members of management. The calculation used in the March 31, 2025 Form 10-Q on the aforementioned 1,486,667 RSUs incorrectly assumed the shares were fully vested as of March 31, 2025, which incorrect assumption resulted in a non-cash share-based compensation expense reflected in such periodic report. However, in reality, the shares vested over 22 months, and therefore, only 15 months vested as of March 31, 2025 which would have resulted in a non-cash share-based compensation expense.

Management of the Company, after discussions with and among the Audit Committee of the Board of Directors, concluded that the Company's unaudited consolidated financial statements as of and for quarter ended March 31, 2025 should no longer be relied upon and should be restated. Such restatement is presented in its entirety in the Company's Form 10-Q for the quarter ended June 30, 2025.